Atlas Trials

Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients

Clinical trial NCT02453867 · UNKNOWN

Trial details

NCT number
NCT02453867
Sponsor
Klemens Budde
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Immunosuppression After Renal Transplantation
Start date
2017-12-01
Primary completion
2018-07-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.